6628 Transcenta Holding Limited HKEX · China

Transcenta Holding (6628) news

Transcenta Holding Limited is a public biotech or pharmaceutical company listed on HKEX under the ticker 6628, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Transcenta Holding news

We have not published a story on Transcenta Holding yet. When there is news, it will appear here.

Questions about Transcenta Holding

What is the ticker symbol of Transcenta Holding?

Transcenta Holding Limited trades under the ticker 6628 on HKEX.

Where is Transcenta Holding listed?

Transcenta Holding Limited is listed on HKEX.

Which country or territory is Transcenta Holding listed under?

Our directory records Transcenta Holding Limited under China.

What does Transcenta Holding do?

Our directory classifies Transcenta Holding Limited as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Transcenta Holding?

The ISIN recorded for Transcenta Holding Limited is KYG9005B1041.

Does aibio.space cover Transcenta Holding?

aibio.space lists Transcenta Holding Limited among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Transcenta Holding?

Companies in our directory listed in the same country and business area as Transcenta Holding: Chongqing Taiji Industry (Group) Co., Zhejiang East Asia Pharmaceutical Co., Zhejiang Int'l Group Co., HeiLongJiang ZBD Pharmaceutical Co., Bide Pharmatech Co., Fuan Pharmaceutical (Group) Co..

Investor discussion: Transcenta Holding

Members talk about Transcenta Holding (6628). Reader posts, not aibio.space reporting, and not investment advice.

Rules

Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at Transcenta Holding, newest first. Each line links the filing it comes from.

Aug 24, 2026Mergers
Transaction under the Listing Rules: MAJOR TRANSACTION DISPOSAL OF CDMO ASSETS AND NOTICE OF EXTRAORDINARY GENERAL MEETING. Source
Aug 6, 2026Mergers
Transaction under the Listing Rules: MAJOR TRANSACTION DISPOSAL OF CDMO ASSETS. Source
Jul 7, 2026Mergers
Transaction under the Listing Rules: DISCLOSEABLE TRANSACTION-REVERSION OF CERTAIN LICENSED ASSETS. Source
Jun 5, 2026Financings
Share or debt issue: PROPOSED RE-ELECTION OF RETIRING DIRECTORS AND PROPOSED APPOINTMENT OF NON-EXECUTIVE DIRECTOR AND PROPOSED APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND PROPOSED RE-APPOINTMENT OF AUDITOR AND PROPOSED GRANTING OF GENERAL MANDATES TO BUY-BACK SHARES AND TO ISSUE SHARES (INCLUDING SALE AND TRANSFER OF TREASURY SHARES) AND NOTICE OF ANNUAL GENERAL MEETING. Source
Apr 8, 2026Listings
Share consolidation: (1) CHANGE OF STOCK SHORT NAME; AND (2) CHANGE OF COMPANY LOGO. Source
Sep 17, 2025Financings
Share or debt issue: COMPLETION OF PLACING OF NEW SHARES UNDER GENERAL MANDATE. Source
Sep 9, 2025Financings
Share or debt issue: PLACING OF NEW SHARES UNDER GENERAL MANDATE. Source

Press releases

Headlines of Transcenta Holding's own announcements, newest first. Each opens the full release on the newswire that carried it.

Oct 20, 2026HKEXnews
VOLUNTARY ANNOUNCEMENT-RECEIPT OF THE FIRST PAYMENT IN RELATION TO THE DISPOSAL OF CDMO ASSETS
Oct 12, 2026HKEXnews
VOLUNTARY ANNOUNCEMENT-BUSINESS UPDATE ON THE GRANT OF CHINA INVENTION PATENTS RELATED TO OSEMITAMAB (TST001) AND ITS COMPANION DIAGNOSTIC ANTIBODY
Sep 30, 2026HKEXnews
CANCELLATION AND GRANT OF AWARD PURSUANT TO THE SHARE INCENTIVE SCHEME
Sep 15, 2026HKEXnews
NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED HOLDERS
Sep 15, 2026HKEXnews
NOTIFICATION LETTER AND REPLY FORM TO REGISTERED HOLDERS
Sep 9, 2026HKEXnews
POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON WEDNESDAY, SEPTEMBER 9, 2026
Aug 28, 2026HKEXnews
(1) APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR; (2) COMPLIANCE WITH RULE 3.10(1) OF THE LISTING RULES; AND (3) GRANT OF AWARD PURSUANT TO THE SHARE INCENTIVE SCHEME
Aug 28, 2026HKEXnews
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2026
Aug 24, 2026HKEXnews
Documents on Display
Aug 24, 2026HKEXnews
NOTICE OF EXTRAORDINARY GENERAL MEETING
Aug 24, 2026HKEXnews
MAJOR TRANSACTION DISPOSAL OF CDMO ASSETS AND NOTICE OF EXTRAORDINARY GENERAL MEETING
Aug 21, 2026HKEXnews
CLOSURE OF REGISTER OF MEMBERS
Aug 6, 2026HKEXnews
MAJOR TRANSACTION DISPOSAL OF CDMO ASSETS
Jul 27, 2026HKEXnews
UPDATE ON MEASURES AND ACTIONS TAKEN IN RESOLVING THE DISCLAIMER OF OPINION IN THE ANNUAL REPORT FOR THE YEAR ENDED DECEMBER 31, 2025
Jul 27, 2026HKEXnews
(1) CHANGE IN THE COMPOSITION OF BOARD COMMITTEES; AND (2) UPDATE ON COMPLIANCE STATUS IN RELATION TO RULES 3.10(1), 3.21 AND 3.27A OF THE LISTING RULES
Jul 7, 2026HKEXnews
DISCLOSEABLE TRANSACTION-REVERSION OF CERTAIN LICENSED ASSETS
Jun 30, 2026HKEXnews
GRANT OF AWARD SHARES AND OPTIONS PURSUANT TO THE SHARE INCENTIVE SCHEME
Jun 30, 2026HKEXnews
(1) POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON TUESDAY, JUNE 30, 2026; (2) CHANGE OF DIRECTORS AND COMPOSITION OF BOARD COMMITTEES; AND (3) NON-COMPLIANCE WITH RULES 3.10(1), 3.21 AND 3.27A OF THE LISTING RULES
Jun 5, 2026HKEXnews
NOTICE OF ANNUAL GENERAL MEETING
Jun 5, 2026HKEXnews
PROPOSED RE-ELECTION OF RETIRING DIRECTORS AND PROPOSED APPOINTMENT OF NON-EXECUTIVE DIRECTOR AND PROPOSED APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND PROPOSED RE-APPOINTMENT OF AUDITOR AND PROPOSED GRANTING OF GENERAL MANDATES TO BUY-BACK SHARES AND TO ISSUE SHARES (INCLUDING SALE AND TRANSFER OF TREASURY SHARES) AND NOTICE OF ANNUAL GENERAL MEETING

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open HKEX:6628 on TradingView.

Listing details

Company: Transcenta Holding Limited
Ticker: 6628
Listing: HKEX
Country or territory: China
Business scope: Pharmaceuticals: Major
ISIN: KYG9005B1041
Last quote in directory: 2026-10-22
Directory source: Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction